Meridian Bioscience3471 River Hills Drive Cincinnati, OH, USA 45244Latest from Meridian BioscienceBusiness InsightsWeek in Review: Abbott Q1 financial results | MDxHealth reimbursement | Meridian Bioscience FDA clearanceBy Leo O'ConnorMDxHealth said Wednesday its Select mdx test for prostate cancer will now be reimbursed in the U.S. for Medicare patients who meet coverage conditions under a specific, foundational Local Coverage Determination (LCD).April 20, 2023FDA ClearanceMeridian Bioscience receives FDA clearance for Shiga toxin assayBy LabPulse.com staff writersMeridian Bioscience is expanding its foodborne immunofluorescent test offering by adding Shiga toxin to the Curian platform.April 20, 2023Business InsightsMagellan former executives charged with concealing lead test inaccuracyBy Leo O'ConnorAccording to an indictment, the former executives allegedly misled customers and the FDA about a serious malfunction that affected the accuracy of Magellan’s LeadCare devices used to test venous blood.April 5, 2023Mergers & AcquisitionsSD Biosensor, SJL Partners complete acquisition of Meridian BioscienceBy LabPulse.com staff writersThe acquisition was agreed upon in July 2022 as an all-cash transaction valued at approximately $1.53 billion.February 1, 2023Financial ResultsMeridian Bioscience Q4 revenues drop 14% on lower COVID-19 testing, misses analysts' estimatesBy LabPulse.com staff writersDiagnostics segment revenue growth was driven by nonmolecular assay products, which increased 22%.November 22, 2022Business InsightsHighly competitive molecular diagnostics market reaches $21B: KaloramaBy Bruce CarlsonThe market largely consists of COVID-19 sales, but future growth in the market will be fueled by other applications, according to Kalorama Information.November 8, 2022Technology CommercializationContract manufacturing market for IVD products to reach $16.1B in 2022: KaloramaBy Bruce CarlsonEvolving trends in IVD contract manufacturing will result in developed economies retaining more than three-fourths of the total global demand.October 4, 2022Financial ResultsMeridian Bioscience Q3 revenues rise 7% on diagnostics salesBy LabPulse.com staff writersThe company said that for the three months ended June 30, Diagnostics net revenues increased 36% year-over-year to $42.4 million, while Life Science net revenues declined 22% year-over-year to $25.4 million.August 4, 2022CollaborationSD Biosensor, SJL Partners to acquire Meridian BioscienceBy Leo O'ConnorUnder the terms of the agreement, shareholders of Cincinnati, OH-based Meridian Bioscience will receive $34 per share in cash, which represents a premium of 16% compared to the firm's one-month average price per share starting Thursday.July 6, 2022PCRMeridian Bioscience launches master mixes for stool analysisBy LabPulse.com staff writersThe company said the master mixes, called the Lyo-Ready Direct DNA qPCR Stool Mix and Lyo-Ready Direct RNA/DNA qPCR Stool Mix, remove the need for nucleic acid extraction and component optimization. As a result, IVD firms can develop faster and more sensitive assays for stool sample analysis. The mixes can be used in liquid or lyophilized format when ambient temperature assay stabilization is needed, Meridian Bioscience added.June 19, 2022HomeMeridian Bioscience releases new master mixesBy LabPulse.com staff writersThe isothermal mixes, Lyo-Ready Direct DNA LAMP Saliva Mix and Lyo-Ready Direct RNA/DNA LAMP Saliva Mix, are designed for saliva and sputum samples. In addition, both mixes are compatible with lyophilization, or freeze drying, the company said.May 18, 2022InfectiousFDA clears Meridian's Curian Campy assayBy LabPulse.com staff writersThe assay was developed for use on the Curian immunofluorescent testing platform and was designed to detect campylobacter-specific antigen, including Campylobacter jejunii, C. coli, C. upsaliensis, and C. lari in human fecal specimens, Meridian said.January 5, 2022PCRMeridian launches new master mixesBy LabPulse.com staff writersMeridian's new mixes, Air-Dryable Direct DNA quantitative PCR (qPCR) Urine and Air-Dryable Direct RNA/DNA qPCR Urine, were designed to overcome the adverse effect of inhibitors present in crude urine samples, which can affect the sensitivity of a molecular assay, the company said.October 27, 2021Diagnostic TechnologiesAMP lineup shows changing of the guard in molecular techBy Bruce CarlsonThe organization's annual meeting draws molecular pathologists, pharmaceutical companies, and IVD vendors. Roche, Abbott Diagnostics, Qiagen, Thermo Fisher, Quidel, and Beckman Coulter are among the vendors that will exhibit at the meeting and also run workshops and presentations. Vendor workshops on molecular pathology are described below.November 5, 2019Clostridium DifficileMeridian acquires GenePOC from DebiopharmBy LabPulse.com staff writersThrough the deal, Meridian will gain GenePOC's revogene product for microbial testing, which incorporates polymerase chain reaction (PCR) techniques for rapid testing in cases where infectious diseases are suspected. The product is marketed in the U.S., Europe, and Canada.April 30, 2019
